Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03344276 · ClinicalTrials.gov registry record · NA
Assessing Neurocognition After Cerebrovascular Intervention
A NA study of Carotid Artery Diseases and Neurocognitive Dysfunction, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03344276: Recruiting NA study of Carotid Artery Diseases and Neurocognitive Dysfunction, sponsored by University of California, San Diego.
NCT03344276 is a NA study of Carotid Artery Diseases and Neurocognitive Dysfunction that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 20 participants, below the 1,671-participant average among 6 other Carotid Artery Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03344276, a NA study of Carotid Artery Diseases and Neurocognitive Dysfunction, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Decreased blood flow to the brain can cause decreased cognitive function. Carotid disease can result in decreased blood flow to the brain. The investigators seek to assess this relationship prospectively through performing a battery of neurocognitive assessments, collection of serum markers of inflammation, and through neuroimaging at two points before intervention (2 months and 1 month before stenting) and at two points after intervention (1 month and 2 months after intervention). The goal is to provide prospective evidence to identify the extent to which carotid stenosis and hypoperfusion of the brain results in diminished neurocognitive performance, and see if serum biomarkers before and after stenting correlate with these findings.
Primary Outcome
Neurocognition will be assessed through a battery of 8 tests to measure cognitive capacity across a range of neurocognitive domains.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Neurocognitive Assessments
- DIAGNOSTIC_TEST Measurements of inflammatory biomarkers
- PROCEDURE Carotid Artery Stenting
Study Locations (1)
California
- UCSD Medical Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-07-15 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT03344276 shows while recruiting
NCT03344276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,671-participant average among 6 other Carotid Artery Diseases trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Carotid Artery Diseases appearing as the primary indexed condition, and to 3 interventions - of which Neurocognitive Assessments is the first listed.
NCT03344276 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03344276 about?
NCT03344276 is a clinical study titled "Assessing Neurocognition After Cerebrovascular Intervention". Decreased blood flow to the brain can cause decreased cognitive function. Carotid disease can result in decreased blood flow to the brain. The investigators seek to assess this relationship prospectively through performing a battery of neurocognitive assessments, collection of serum markers of infla...
What is the current status of trial NCT03344276?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-07-15. Estimated completion is 2025-12.
What conditions does trial NCT03344276 study?
This clinical trial studies the following conditions: Carotid Artery Diseases, Neurocognitive Dysfunction.
What interventions are being tested in trial NCT03344276?
The interventions under investigation include: Neurocognitive Assessments (DIAGNOSTIC_TEST), Measurements of inflammatory biomarkers (DIAGNOSTIC_TEST), Carotid Artery Stenting (PROCEDURE).
Who is sponsoring clinical trial NCT03344276?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03344276 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Artery Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
RECRUITING · NA
-
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
ACTIVE NOT RECRUITING · NA
-
Study of Carotid Occlusion and Neurocognition
COMPLETED · NA
-
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
COMPLETED · NA
-
The CREST-2 Registry
RECRUITING
-
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI